A nasal spray is thus generally easier to administer than an intramuscular or subcutaneous injection
In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
Communications Biology, 8 (1), 1-10
Research has explored its potential role in supporting the healing of muscles, tendons, ligaments, and the gastrointestinal tract, as well as its involvement in tissue repair and cellular recovery processes
Peptides with a short half-life (e.g., Ipamorelin , GHRP-6) are often split into 2-3 daily doses to maintain stable blood levels
